AliveCor’s Smartphone-Linked ECG First Product Assessed Under UK’s Rapid HTA Pilot
NICE’s recently launched early value assessment (EVA) pilot has hit a milestone this month, with AliveCor’s KardiaMobile 6L the first product to be given the go-ahead for NHS use in England under the scheme.
You may also be interested in...
UK’s NICE Says ‘Light Touch’ HTA Evaluation Will Support Innovation
The UK’s health technology assessment body recognizes that its traditional product evaluation processes are too slow for innovative medtech products. Its new “conditional recommendation” pathway aims to fix this.
UK’s Early Value Assessment Pilot Is ‘Catalyst’ For Wider Change - NICE
NICE’s early value assessment (EVA) pilot for medtech will have failed unless it changes the way that medical devices “as a whole” are evaluated in the UK, according to Mark Chapman, the organization’s interim director of medical technology.
England: HTA Body NICE Makes Big RWE Push
England’s health technology appraisal institute, NICE, has published its real-world evidence framework.